β-Arrestin scaffolds and signaling elements essential for the obestatin/GPR39 system that determine the myogenic program in human myoblast cells

Cellular and Molecular Life Sciences

Volumn 73, Issue 3, 2016, Pages 617-635

  Santos Zas, Icía ^a,b   Gurriarán Rodríguez, Uxía ^a,f   Cid Díaz, Tania ^a,b   Figueroa, Gabriela ^a   González Sánchez, Jessica ^a,b   Bouzo Lorenzo, Mónica ^a,b   Mosteiro, Carlos S ^a,b   Señarís, José ^a   Casanueva, Felipe F ^b,c   Casabiell, Xesús ^d   Gallego, Rosalía ^d   Pazos, Yolanda ^a,b   Mouly, Vincent ^e   Camiña, Jesús P ^a,b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^d UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^e INSERM   (France)

^f OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Obestatin signaling; Skeletal muscle; Skeletal muscle regeneration

Indexed keywords

BETA ARRESTIN 1; BETA ARRESTIN 2; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CYCLIN DEPENDENT KINASE INHIBITOR 1C; EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 39; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OBESTATIN; PROTEIN C JUN; PROTEIN KINASE B; PROTEIN P21; PROTEIN TYROSINE KINASE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR JUND; UNCLASSIFIED DRUG; BETA ARRESTIN; GHRELIN; GPR39 PROTEIN, HUMAN; OBESTATIN, HUMAN; RETINA S ANTIGEN;

ADULT; ARTICLE; AUTOCRINE EFFECT; CELL CYCLE; CELL DIFFERENTIATION; CELL MEMBRANE; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; HORMONE ACTION; HUMAN; HUMAN CELL; IMMORTALIZED CELL LINE; MITOGENESIS; MITOSIS INHIBITION; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; PARACRINE SIGNALING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; CHEMISTRY; CYTOLOGY; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SKELETAL MUSCLE CELL;

ARRESTINS; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; GHRELIN; HUMANS; MUSCLE DEVELOPMENT; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; PHOSPHORYLATION; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84954401886     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-015-1994-z     Document Type: Article

References (85)

1. Tedesco FS, Dellavalle A, Diaz-Manera J, Messina G, Cossu G (2010) Repairing skeletal muscle, regenerative potential of skeletal muscle stem cells. J Clin Invest 120:11-19
2. Yin H, Price F, Rudnicki MA (2013) Satellite cells and the muscle stem cell niche. Physiol Rev 93:23-67
3. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA (2005) Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433:760-764
4. Brack AS, Conboy MJ, Roy S, Lee M, Kuo CJ, Keller C, Rando TA (2007) Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 317:807-810
5. Le Bihan MC, Bigot A, Jensen SS, Dennis J, Rogowska-Wrzesinska A, Lainé J, Gache V, Furling D, Jensen ON, Voit T, Mouly V, Coulton GR, Butler-Browne G (2012) In-depth analysis of the secretome identifies three major independent secretory pathways in differentiating human myoblasts. J Proteomics 77:344-356
6. Duguez S, Duddy W, Johnston H, Lainé J, Le Bihan MC, Brown KJ, Bigot A, Hathout Y, Butler-Browne G, Partridge T (2013) Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion. Cell Mol Life Sci 70:2159-2174
7. Gurriarán-Rodríguez U, Santos-Zas I, Al-Massadi O, Mosteiro CS, Beiroa D, Nogueiras R, Crujeiras AB, Seoane LM, Señarís J, García-Caballero T, Gallego R, Casanueva FF, Pazos Y, Camiña JP (2012) The obestatin/GPR39 system is up-regulated by muscle injury and functions as an autocrine regenerative system. J Biol Chem 287:38379-38389
8. Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, Hsueh AJ (2005) Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310:996-999
9. Trovato L, Gallo D, Settanni F, Gesmundo I, Ghigo E, Granata R (2014) Obestatin: is it really doing something? Front Horm Res 42:175-185
10. Gurriarán-Rodríguez U, Al-Massadi O, Roca-Rivada A, Crujeiras AB, Gallego R, Pardo M, Seoane LM, Pazos Y, Casanueva FF, Camiña JP (2011) Obestatin as a regulator of adipocyte metabolism and adipogenesis. J Cell Mol Med 15:1927-1940
11. Granata R, Settanni F, Gallo D, Trovato L, Biancone L, Cantaluppi V, Nano R, Annunziata M, Campiglia P, Arnoletti E, Ghè C, Volante M, Papotti M, Muccioli G, Ghigo E (2008) Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function. Diabetes 57:967-979
12. Alvarez CJ, Lodeiro M, Theodoropoulou M, Camiña JP, Casanueva FF, Pazos Y (2009) Obestatin stimulates Akt signalling in gastric cancer cells through beta-arrestin-mediated epidermal growth factor receptor transactivation. Endocr Relat Cancer 16:599-611
13. Gurriarán-Rodríguez U, Al-Massadi O, Crujeiras AB, Mosteiro CS, Amil-Diz M, Beiroa D, Nogueiras R, Seoane LM, Gallego R, Pazos Y, Casanueva FF, Camiña JP (2011) Preproghrelin expression is a key target for insulin action on adipogenesis. J Endocrinol 210:R1-R7
14. Gurriarán-Rodríguez U, Santos-Zas I, González-Sánchez J, Beiroa D, Moresi V, Mosteiro C, Lin W, Viñuela JE, Señarís J, García-Caballero T, Casanueva FF, Nogueiras R, Gallego R, Renaud JM, Adamo S, Pazos Y, Camiña JP (2015) The action of obestatin in skeletal muscle repair, stem cell expansion, muscle growth, and microenvironment remodeling. Mol Ther 23:1003-1021. doi: 10.1038/mt.2015.40
15. Bareja A, Holt JA, Luo G, Chang C, Lin J, Hinken AC, Freudenberg JM, Kraus WE, Evans WJ, Billin AN (2014) Human and mouse skeletal muscle stem cells, convergent and divergent mechanisms of myogenesis. PLoS One 9:e90398
16. Bachrach E, Li S, Perez AL, Schienda J, Liadaki K, Volinski J, Flint A, Chamberlain J, Kunkel LM (2004) Systemic delivery of human microdystrophin to regenerating mouse dystrophic muscle by muscle progenitor cells. Proc Natl Acad Sci USA 101:3581-3586
17. Boldrin L, Neal A, Zammit PS, Muntoni F, Morgan JE (2012) Donor satellite cell engraftment is significantly augmented when the host niche is preserved and endogenous satellite cells are incapacitated. Stem Cells 30:1971-1984
18. Partridge TA (2013) The mdx mouse model as a surrogate for Duchenne muscular dystrophy. FEBS J 280:4177-4186
19. Olguin HC, Olwin BB (2004) Pax-7 up-regulation inhibits myogenesis and cell cycle progression in satellite cells, a potential mechanism for self-renewal. Dev Biol 275:375-388
20. Zammit PS, Golding JP, Nagata Y, Hudon V, Partridge TA, Beauchamp JR (2004) Muscle satellite cells adopt divergent fates, a mechanism for self-renewal. J Cell Biol 166:347-357
21. Cerletti M, Jang YC, Finley LW, Haigis MC, Wagers AJ (2012) Short-term calorie restriction enhances skeletal muscle stem cell function. Cell Stem Cell 10:515-519
22. Liu W, Wen Y, Bi P, Lai X, Liu XS, Kuang S (2012) Hypoxia promotes satellite cell self-renewal and enhances the efficiency of myoblast transplantation. Development 139:2857-2865
23. Tajbakhsh S, Rocancourt D, Cossu G, Buckingham M (1997) Redefining the genetic hierarchies controlling skeletal myogenesis, Pax-3 and Myf-5 act upstream of MyoD. Cell 89:127-138
24. Sabourin LA, Girgis-Gabardo A, Seale P, Asakura A, Rudnicki MA (1999) Reduced differentiation potential of primary MyoD-/- myogenic cells derived from adult skeletal muscle. J Cell Biol 144:631-643
25. Bajard L, Relaix F, Lagha M, Rocancourt D, Daubas P, Buckingham ME (2006) A novel genetic hierarchy functions during hypaxial myogenesis, Pax3 directly activates Myf5 in muscle progenitor cells in the limb. Genes Dev 20:2450-2464
26. Buchberger A, Freitag D, Arnold HH (2007) A homeo-paired domain-binding motif directs Myf5 expression in progenitor cells of limb muscle. Development 134:1171-1180
27. McKinnell IW, Ishibashi J, Le Grand F, Punch VG, Addicks GC, Greenblatt JF, Dilworth FJ, Rudnicki MA (2008) Pax7 activates myogenic genes by recruitment of a histone methyltransferase complex. Nat Cell Biol 10:77-84
28. Kawabe Y, Wang YX, McKinnell IW, Bedford MT, Rudnicki MA (2012) Carm1 regulates Pax7 transcriptional activity through MLL1/2 recruitment during asymmetric satellite stem cell divisions. Cell Stem Cell 11:333-345
29. Fearon KC, Glass DJ, Guttridge DC (2012) Cancer cachexia, mediators, signaling, and metabolic pathways. Cell Metab 16:153-166
30. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, Finnerty CC, López CM, Honari S, Moore EE, Minei JP, Cuschieri J, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Jeschke MG, Klein MB, Gamelli RL, Gibran NS, Brownstein BH, Miller-Graziano C, Calvano SE, Mason PH, Cobb JP, Rahme LG, Lowry SF, Maier RV, Moldawer LL, Herndon DN, Davis RW, Xiao W, Tompkins RG (2013) Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA 110:3507-3512
31. Zhu CH, Mouly V, Cooper RN, Mamchaoui K, Bigot A, Shay JW, Di Santo JP, Butler-Browne GS, Wright WE (2007) Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4, consequences in aging muscle and therapeutic strategies for muscular dystrophies. Aging Cell 6:515-523
32. Mamchaoui K, Trollet C, Bigot A, Negroni E, Chaouch S, Wolff A, Kandalla PK, Marie S, Di Santo J, St Guily JL, Muntoni F, Kim J, Philippi S, Spuler S, Levy N, Blumen SC, Voit T, Wright WE, Aamiri A, Butler-Browne G, Mouly V (2011) Immortalized pathological human myoblasts, towards a universal tool for the study of neuromuscular disorders. Skelet Muscle 1:34
33. Shiomi K, Kiyono T, Okamura K, Uezumi M, Goto Y, Yasumoto S, Shimizu S, Hashimoto N (2011) CDK4 and cyclin D1 allow human myogenic cells to recapture growth property without compromising differentiation potential. Gene Ther 18:857-866
34. Zhou H, Rokach O, Feng L, Munteanu I, Mamchaoui K, Wilmshurst JM, Sewry C, Manzur AY, Pillay K, Mouly V, Duchen M, Jungbluth H, Treves S, Muntoni F (2013) RyR1 deficiency in congenital myopathies disrupts excitation-contraction coupling. Hum Mutat 34:986-996
35. Rokach O, Ullrich ND, Rausch M, Mouly V, Zhou H, Muntoni F, Zorzato F, Treves S (2013) Establishment of a human skeletal muscle-derived cell line, biochemical, cellular and electrophysiological characterization. Biochem J 455:169-177
36. Shukla AK, Xiao K, Lefkowitz RJ (2011) Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling. Trends Biochem Sci 36:457-469
37. Leloup L, Daury L, Mazères G, Cottin P, Brustis JJ (2007) Involvement of the ERK/MAP kinase signalling pathway in milli-calpain activation and myogenic cell migration. Int J Biochem Cell Biol 39:1177-1189
38. Knight JDR, Kothary R (2011) The myogenic kinome: protein kinases critical to mammalian skeletal myogenesis. Skelet Muscle 1:29
39. Winter B, Arnold HH (2000) Activated raf kinase inhibits muscle cell differentiation through a MEF2-dependent mechanism. J Cell Sci 113:4211-4220
40. Gredinger E, Gerber AN, Tamir Y, Tapscott SJ, Bengal E (1998) Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells. J Biol Chem 273:10436-10444
41. Wu Z, Woodring PJ, Bhakta KS, Tamura K, Wen F, Feramisco JR, Karin M, Wang JY, Puri PL (2000) p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol Cell Biol 20:3951-3964
42. Anjum R, Blenis J (2008) The RSK family of kinases, emerging roles in cellular signaling. Nature Mol Cel 9:747-758
43. Romeo Y, Zhang X, Roux PP (2012) Regulation and function of the RSK family of protein kinases. Biochem J 441:553-569
44. Bigot A, Jacquemin V, Debacq-Chainiaux F, Butler-Browne GS, Toussaint O, Furling D, Mouly V (2008) Replicative aging down-regulates the myogenic regulatory factors in human myoblasts. Biol Cell 100:189-199
45. Zalc A, Hayashi S, Auradé F, Bröhl D, Chang T, Mademtzoglou D, Mourikis P, Yao Z, Cao Y, Birchmeier C, Relaix F (2014) Antagonistic regulation of p57kip2 by Hes/Hey downstream of Notch signaling and muscle regulatory factors regulates skeletal muscle growth arrest. Development 141:2780-2790
46. Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103:239-252
47. Perdiguero E, Ruiz-Bonilla V, Gresh L, Hui L, Ballestar E, Sousa-Victor P, Baeza-Raja B, Jardí M, Bosch-Comas A, Esteller M, Caelles C, Serrano AL, Wagner EF, Muñoz-Cánoves P (2007) Genetic analysis of p38 MAP kinases in myogenesis, fundamental role of p38alpha in abrogating myoblast proliferation. EMBO J 26:1245-1256
48. Khurana A, Dey CS (2004) Involvement of c-Jun N-terminal kinase activities in skeletal muscle differentiation. J Muscle Res Cell Motil 25:645-655
49. Alter J, Rozentzweig D, Bengal E (2008) Inhibition of myoblast differentiation by tumor necrosis factor alpha is mediated by c-Jun N-terminal kinase 1 and leukemia inhibitory factor. J Biol Chem 283:23224-23234
50. Shaulian E, Karin M (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4:E131-E136
51. Vinciguerra M, Vivacqua A, Fasanella G, Gallo A, Cuozzo C, Morano A, Maggiolini M, Musti AM (2004) Differential phosphorylation of c-Jun and JunD in response to the epidermal growth factor is determined by the structure of MAPK targeting sequences. J Biol Chem 279:9634-9641
52. Pillebout E, Weitzman JB, Burtin M, Martino C, Federici P, Yaniv M, Friedlander G, Terzi F (2003) JunD protects against chronic kidney disease by regulating paracrine mitogens. J Clin Invest 112:843-852
53. Luther J, Driessler F, Megges M, Hess A, Herbort B, Mandic V, Zaiss MM, Reichardt A, Zech C, Tuckermann JP, Calkhoven CF, Wagner EF, Schett G, David JP (2011) Elevated Fra-1 expression causes severe lipodystrophy. J Cell Sci 124:1465-1476
54. Alli NS, Yang EC, Miyake T, Aziz A, Collins-Hooper H, Patel K, McDermott JC (2013) Signal-dependent fra-2 regulation in skeletal muscle reserve and satellite cells. Cell Death Dis 4:e692
55. Rajabi HN, Takahashi C, Ewen ME (2014) Retinoblastoma protein and MyoD function together to effect the repression of Fra-1 and in turn cyclin D1 during terminal cell cycle arrest associated with myogenesis. J Biol Chem 289:23417-23427
56. Andreucci JJ, Grant D, Cox DM, Tomc LK, Prywes R, Goldhamer DJ, Rodrigues N, Bédard PA, McDermott JC (2002) Composition and function of AP-1 transcription complexes during muscle cell differentiation. J Biol Chem 277:16426-16432
57. Lluís F, Perdiguero E, Nebreda AR, Muñoz-Cánoves P (2006) Regulation of skeletal muscle gene expression by p38 MAP kinases. Trends Cell Biol 16:36-44
58. Cabane C, Englaro W, Yeow K, Ragno M, Dérijard B (2003) Regulation of C2C12 myogenic terminal differentiation by MKK3/p38alpha pathway. Am J Physiol Cell Physiol 284:C658-C666
59. Cuadrado A, Nebreda AR (2010) Mechanisms and functions of p38 MAPK signalling. Biochem J 429:403-417
60. During RL, Gibson BG, Li W, Bishai EA, Sidhu GS (2007) Anthrax lethal toxin paralyzes actin-based motility by blocking Hsp27 phosphorylation. EMBO J 26:2240-2250
61. Li T, Ying L, Wang H, Li N, Fu W, Guo Z, Xu L (2012) Microcystin-LR induces ceramide to regulate PP2A and destabilize cytoskeleton in HEK293 cells. Toxicol Sci 128:147-157
62. Matsushima-Nishiwaki R, Takai S, Adachi S, Minamitani C, Yasuda E, Noda T, Kato K, Toyoda H, Kaneoka Y, Yamaguchi A, Kumada T, Kozawa O (2008) Phosphorylated heat shock protein 27 represses growth of hepatocellular carcinoma via inhibition of extracellular signal-regulated kinase. J Biol Chem 283:18852-18860
63. Venkatakrishnan CD, Dunsmore K, Wong H, Roy S, Sen CK, Wani A, Zweier JL, Ilangovan G (2008) HSP27 regulates p53 transcriptional activity in doxorubicin-treated fibroblasts and cardiac H9c2 cells, p21 upregulation and G2/M phase cell cycle arrest. Am J Physiol Heart Circ Physiol 294:H1736-H1744
64. Kamradt MC, Chen F, Sam S, Cryns VL (2002) The small heat shock protein alpha B-crystallin negatively regulates apoptosis during myogenic differentiation by inhibiting caspase-3 activation. J Biol Chem 277:38731-38736
65. Wu M, Falasca M, Blough ER (2011) Akt/protein kinase B in skeletal muscle physiology and pathology. J Cell Physiol 226:29-36
66. Rotwein P, Wilson EM (2009) Distinct actions of Akt1 and Akt2 in skeletal muscle differentiation. J Cell Physiol 219:503-511
67. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJ (2001) Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 3:1009-1013
68. Sandri M (2008) Signaling in muscle atrophy and hypertrophy. Physiology 23:160-170
69. Scicchitano BM, Spath L, Musarò A, Molinaro M, Rosenthal N, Nervi C, Adamo S (2005) Vasopressin-dependent myogenic cell differentiation is mediated by both Ca2+/calmodulin-dependent kinase and calcineurin pathways. Mol Biol Cell 16:3632-3641
70. Chin ER (2004) The role of calcium and calcium/calmodulin-dependent kinases in skeletal muscle plasticity and mitochondrial biogenesis. Proc Nutr Soc 63:279-286
71. Bassel-Duby R, Olson EN (2006) Signaling pathways in skeletal muscle remodeling. Ann Rev Biochem 75:19-37
72. Cam H, Griesmann H, Beitzinger M, Hofmann L, Beinoraviciute-Kellner R, Sauer M, Hüttinger-Kirchhof N, Oswald C, Friedl P, Gattenlöhner S, Burek C, Rosenwald A, Stiewe T (2006) p53 family members in myogenic differentiation and rhabdomyosarcoma development. Cancer Cell 10:281-293
73. Chen AE, Ginty DD, Fan CM (2005) Protein kinase A signalling via CREB controls myogenesis induced by Wnt proteins. Nature 433:317-322
74. Berdeaux R, Goebel N, Banaszynski L, Takemori H, Wandless T, Shelton GD, Montminy M (2007) SIK1 is a class II HDAC kinase that promotes survival of skeletal myocytes. Nat Med 13:597-603
75. Mourkioti F, Rosenthal N (2005) IGF-1, inflammation, and stem cells, interactions during muscle regeneration. Trends Immunol 26:535-542
76. Matheny RW Jr, Nindl BC, Adamo ML (2010) Mechano-growth factor, a putative product of IGF-I gene expression involved in tissue repair and regeneration. Endocrinology 151:865-875
77. Seals DF, Courtneidge SA (2003) The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev 17:7-30
78. Edwards DR, Handsley MM (2008) The ADAM metalloproteinases. Mol Aspects Med 29:258-289
79. Roskoski R Jr (2014) The ErbB/HER family of protein-tyrosine kinases and cancer. Pharmacol Res 79:34-74
80. Citri A, Yarden Y (2006) EGF-ERBB signalling, towards the systems level. Nature Rev Mol Cell Biol 7:505-516
81. Sato K (2014) Cellular Functions Regulated by Phosphorylation of EGFR on Tyr845. Int J Mol Sci 14:10761-10790
82. George AJ, Thomas WG, Hannan RD (2010) The renin-angiotensin system and cancer, old dog, new tricks. Nat Rev Cancer 10:745-759
83. George AJ, Hannan RD, Thomas WG (2013) Unravelling the molecular complexity of GPCR-mediated EGFR transactivation using functional genomics approaches. FEBS J 280:5258-5268
84. Wisler JW, Xiao K, Thomsen AR, Lefkowitz RJ (2014) Recent developments in biased agonism. Curr Opin Cell Biol 27:18-24
85. Reiter E, Ahn S, Shukla AK, Lefkowitz RJ (2012) Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors. Annu Rev Pharmacol Toxicol 52:179-197